Effect of the breast-cancer resistance protein on atypical multidrug resistance
- 1 November 2000
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 1 (3) , 169-175
- https://doi.org/10.1016/s1470-2045(00)00032-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsProceedings of the National Academy of Sciences, 2000
- MRP3, an organic anion transporter able to transport anti-cancer drugsProceedings of the National Academy of Sciences, 1999
- Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell linesBritish Journal of Cancer, 1996
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell lineBritish Journal of Cancer, 1991
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 1985
- DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.Molecular and Cellular Biology, 1982